Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retinoic acid for Cushing's disease
2008-006379-65Phase 3Active
- Sponsor
- Istituto Auxologico Italiano
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tretinoin in Corticotropin adenoma (ACTHoma), sponsored by Istituto Auxologico Italiano. Primary endpoints: Efficacy based on ACTH and cortisol reduction, Improvement in clinical features of hypercortisolism and 1 more. Started Nov 2008; status: active.
02
Drugs
tretinoin
03
Conditions
Corticotropin adenoma (ACTHoma)
Beyond the preview
Go deeper on 2008-006379-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006379-65.